Skip to main content
. 2013 Jun 5;7(4):397–406. doi: 10.1111/crj.12026

Figure 2.

Figure 2

CONsolidated Standards of Reporting Trials (CONSORT)/patient flow diagram. *Placebo inhaler plus prednisolone 10 mg once-daily/morning Days 36–42. AE, adverse event; AM, morning; FF, fluticasone furoate; ITT, intent-to-treat; PM, evening; VI, vilanterol.